臨床試驗

Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration

NCT：NCT04567303 · COMPLETED

NCT IDNCT04567303

狀態COMPLETED

開始日期2020-10-28

完成時間2026-08-25

SponsorHoffmann-La Roche (INDUSTRY)

First posted2020-09-28

Last updated2026-09-14

簡要摘要

This is a first in-human study to investigate the safety, tolerability and efficacy of zifibancimig administered through intravitreal (IVT) injections and via the port delivery (PD) implant in participants with neovascular age-related macular degeneration (nAMD).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。